Annual Cash & Cash Equivalents
$4.58B$291.85M-5.99%
Summary
- Current Value
- As of today, GSK annual cash & cash equivalents is $4.58B, down -5.99% on
- Historical Performance
- GSK annual cash & cash equivalents is down -51.65% over the past 3 years, down -47.39% over the past 5 years
- All-Time High Comparison
- GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on
- 3-Year Low Comparison
- GSK annual cash & cash equivalents is at its 3-year low
- Sector Comparison
- GSK annual cash & cash equivalents is higher than 97.62% of companies in Healthcare sector
Cash and Cash Equivalents Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $4.58B | -6.0% | -51.6% | -47.4% | -53.8% | |
| Quarterly Cash & Cash Equivalents | $4.12B | -16.9% | -50.1% | -16.2% | -58.1% | |
| Price | $49.52 | +26.2% | +39.7% | +15.7% | +17.6% | |
| Annual Current Assets | $23.55B | +10.6% | -5.7% | -14.9% | -6.2% | |
| Annual Total Liabilities | $60.75B | +4.6% | +0.9% | -25.5% | +19.4% | |
| Annual Working Capital | -$5.22B | +11.3% | -112.6% | -100.9% | -202.8% | |
| Annual Net Income | $8.29B | +119.8% | +36.7% | +1.2% | +189.8% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $9.48B | N/A | -51.6% |
| 5Y | $9.48B | -51.6% | |
| All | $11.21B | -59.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.58B | at low | |
| 5Y | $4.58B | at low | |
| All | $37.03M | >+9999.0% |
Cash and Cash Equivalents History
FAQ
- What is the current annual cash & cash equivalents of GSK?
- As of today, GSK annual cash & cash equivalents is $4.58B
- What is 1-year change in GSK annual cash & cash equivalents?
- GSK annual cash & cash equivalents is down -5.99% year-over-year
- What is 3-year change in GSK annual cash & cash equivalents?
- GSK annual cash & cash equivalents is down -51.65% over the past 3 years
- How far is GSK annual cash & cash equivalents from its all-time high?
- GSK annual cash & cash equivalents is currently -59.13% below its historical high of $11.21B set on December 31, 2009
- How does GSK annual cash & cash equivalents rank versus sector peers?
- GSK annual cash & cash equivalents is higher than 97.62% of companies in Healthcare sector
- When is GSK next annual earnings release?
- As of today, the next annual earnings release for GSK has not been scheduled
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Quarterly Cash & Cash Equivalents
$4.12B$417.85M-9.20%
Summary
- Current Value
- As of today, GSK quarterly cash & cash equivalents is $4.12B, down -9.20% on
- Historical Performance
- GSK quarterly cash & cash equivalents is down -16.87% year-over-year, down -50.15% over the past 3 years
- All-Time High Comparison
- GSK quarterly cash & cash equivalents is currently -73.46% below its historical high of $15.54B set on
- 3-Year Low Comparison
- GSK quarterly cash & cash equivalents is +9.33% above its 3-year low of $3.77B reached on
- Sector Comparison
- GSK quarterly cash & cash equivalents is higher than 97.31% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $4.12B | -9.2% | -16.9% | -50.1% | -16.2% | |
| Annual Cash & Cash Equivalents | $4.58B | – | -6.0% | -51.6% | -47.4% | |
| Price | $49.52 | -2.8% | +26.2% | +39.7% | +15.7% | |
| Quarterly Current Assets | $23.31B | -0.5% | -3.8% | -5.3% | -4.0% | |
| Quarterly Total Liabilities | $59.14B | -1.3% | -3.9% | -1.6% | -22.8% | |
| Quarterly Working Capital | -$5.28B | +14.3% | -42.3% | -50.4% | +0.1% | |
| Quarterly Net Income | $742.26M | -70.0% | -66.2% | -66.0% | -58.2% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.96B | N/A | -16.9% |
| 3Y | $8.27B | N/A | -50.1% |
| 5Y | $10.37B | -60.3% | |
| All | $15.54B | -73.5% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.12B | at low | |
| 3Y | $3.77B | +9.3% | |
| 5Y | $3.77B | +9.3% | |
| All | $37.03M | >+9999.0% |
Quarterly Cash & Cash Equivalents History
FAQ
- What is the current quarterly cash & cash equivalents of GSK?
- As of today, GSK quarterly cash & cash equivalents is $4.12B
- What is GSK quarterly cash & cash equivalents most recent change?
- GSK quarterly cash & cash equivalents was down -9.20% on June 30, 2026
- What is 1-year change in GSK quarterly cash & cash equivalents?
- GSK quarterly cash & cash equivalents is down -16.87% year-over-year
- How far is GSK quarterly cash & cash equivalents from its all-time high?
- GSK quarterly cash & cash equivalents is currently -73.46% below its historical high of $15.54B set on March 31, 2015
- How does GSK quarterly cash & cash equivalents rank versus sector peers?
- GSK quarterly cash & cash equivalents is higher than 97.31% of companies in Healthcare sector
- When is GSK next earnings release?
- The next earnings release for GSK is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- GSK Official Website www.gsk.com
- GSK Profile on Yahoo Finance finance.yahoo.com/quote/GSK
- GSK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/gsk